HomeIBRX • NASDAQ
add
Immunitybio Inc
Previous close
$5.11
Day range
$4.92 - $7.74
Year range
$1.25 - $7.74
Market cap
4.95B USD
Avg Volume
5.54M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Top news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 139.00K | 90.41% |
Operating expense | 84.64M | 0.35% |
Net income | -233.39M | -115.67% |
Net profit margin | -167.91K | -13.27% |
Earnings per share | — | — |
EBITDA | -79.94M | -1.13% |
Effective tax rate | 0.02% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 266.46M | 148.60% |
Total assets | 504.45M | 39.21% |
Total liabilities | 1.09B | 34.26% |
Total equity | -585.94M | — |
Shares outstanding | 673.95M | — |
Price to book | -5.87 | — |
Return on assets | -45.10% | — |
Return on capital | -69.63% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -233.39M | -115.67% |
Cash from operations | -115.27M | -27.05% |
Cash from investing | 2.25M | 111.90% |
Cash from financing | 200.54M | 82.41% |
Net change in cash | 87.49M | 18,127.08% |
Free cash flow | -90.77M | -33.79% |
About
CEO
Founded
2014
Website
Employees
628